Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-097881
Filing Date
2022-09-06
Accepted
2022-09-06 16:35:55
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2224917d1_s3.htm S-3 240116
2 EXHIBIT 5.1 tm2224917d1_ex5-1.htm EX-5.1 9610
3 EXHIBIT 23.1 tm2224917d1_ex23-1.htm EX-23.1 2697
4 EXHIBIT 23.2 tm2224917d1_ex23-2.htm EX-23.2 2056
5 EXHIBIT 107 tm2224917d1_ex107.htm EX-FILING FEES 15939
6 GRAPHIC tm2224917d1_ex5-1image002.jpg GRAPHIC 4464
7 GRAPHIC tm2224917d1_s3img.jpg GRAPHIC 4341
  Complete submission text file 0001104659-22-097881.txt   284181
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267294 | Film No.: 221228682
SIC: 2834 Pharmaceutical Preparations